Searched for
WATSON PHARMACEUTICALS
Lupin appoints Dr Ranjana Pathak as chief quality officerDr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla...- India to see a 6.4% average salary increase in 2021: SurveyThe increase is marginally higher than the average actual increase of 5.9% in 2020. 37% of the surveyed companies in India have projected a...
- Strides Arcolab completes acquisition of Aspen's generic business in AustraliaThe acquisition included access to the product pipeline that was under development by Aspen and a number of major product launches slated f...
- Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...
- Teva settles patent dispute with Orchid PharmaTeva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...
- Windfall likely for Ranbaxy Laboratories after FDA says no to Watson PharmaceuticalsThe US drug regulator's refusal to allow Watson Pharma to launch generic version of diabetes drug could mean windfall for Ranbaxy, accordin...
- Teva Pharmaceuticals will not be launching Atorvastatin, generic version of LipitorIsrael's Teva Pharmaceuticals will not launch atorvastatin, the generic version of Lipitor, that will help Indian cos Ranbaxy and Dr Reddy'...
- Strides Arcolab January-March net profit zooms to Rs 642 croreThe Bangalore-headquartered firm had sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals.
- Ranbaxy Laboratories close to claiming 50% share of atorvastatin market in 6-month exclusivity periodA Ranbaxy spokesman declined comment but people familiar with Ranbaxy marketing plans said the company's share would cross 50% in about a m...
- Pfizer recalls 1 million contraceptive medicine packsPfizer recalled 1 mn birth-control packs after discovering that pills were mixed up inside the packages, possibly putting women at risk.
- Strides sells Australian unit to Watson Pharma for AUD 375 mnDrug firm Strides Arcolab today said it has sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals fo...
- Strides Arcolab shares hit lifetime high on Ascent saleShares of drug firm Strides Arcolab skyrocketed by 20 per cent to hit a lifetime high on the bourses today after the company sold its entir...
- Strides Arcolab sold 94% stake in its subsidiary Ascent Pharma health to Watson PharmaceuticalsArcolab sold 94% stake in its subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for an undisclosed amount.
- Ranbaxy set to get USFDA nod for Lipitor generic launch"The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline", a per...
- Ranbaxy Labs shares tumble as Lipitor patent expiresDefying the broader market, Ranbaxy fell by as much as 3.88 per cent to close at Rs 434.80 on the BSE.
- Watson starts selling generic Lipitor in US, Ranbaxy mumUS-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...
- Pfizer marketing may hit Ranbaxy’s profit from low-cost lipitor versionLate last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lip...
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.
- Reliance, Cipla in talks for retail pactIf the deal is sealed, Cipla will supply generic pharmaceutical products to Reliance Retail.
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.
Load More
